Q1 FY27 results, MD reappointment, Rs 198 Cr fundraise done

Revenue growth above 20%Profit growth above 25%Results View source PDF Explain this filing

SANSTAR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.6%Reaction day

₹112.80

prior close

₹110.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-1.7% vs market

Other Agricultural Products peers, median of 54sector+0.0%-1.6% vs sector

On the reaction day the stock moved 1.7 pts less than Nifty Microcap 250 and 1.6 pts less than its Other Agricultural Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.4

10m

-1.5

15m

-2.1

30m

-0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.6+0.1-1.7+0.0-1.6

Next day

-3.8+0.2-4.0+1.0-4.8

-5.2+0.6-5.8+0.7-5.9

-5.2-0.0-5.1-0.0-5.1

-6.4+0.5-6.9+0.5-6.9

-6.4+0.8-7.1+1.2-7.6

-3.6+0.6-4.2+0.9-4.5

15d

-2.0+1.3-3.3+0.1-2.1

-1.1-1.4+0.3+0.4-1.5

-13.3-0.6-12.7+3.1-16.3

—————

UpDownMarket · Nifty Microcap 250Sector · Other Agricultural Products peers, median of 54Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q1 FY27 unaudited results. Standalone revenue Rs 206.16 Cr, up about 28 percent YoY from Rs 160.66 Cr. Net profit Rs 9.21 Cr vs loss of Rs 0.33 Cr last year. Completed Rs 198.27 Cr preferential issue to Corn Products Development Inc at Rs 110 per share. Reappointed MD and two Joint MDs for 5 years. New nominee director from Ingredion and an independent director appointed. 44th AGM on September 23, 2026.

Likely market impact

Strong revenue and profit turnaround YoY. Strategic investor on board. Governance continuity via MD reappointment. AGM in September.